BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11468171)

  • 1. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
    Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
    Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation.
    Comenzo RL; Wally J; Kica G; Murray J; Ericsson T; Skinner M; Zhang Y
    Br J Haematol; 1999 Sep; 106(3):744-51. PubMed ID: 10468868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.
    Perfetti V; Casarini S; Palladini G; Vignarelli MC; Klersy C; Diegoli M; Ascari E; Merlini G
    Blood; 2002 Aug; 100(3):948-53. PubMed ID: 12130507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).
    Abraham RS; Geyer SM; Price-Troska TL; Allmer C; Kyle RA; Gertz MA; Fonseca R
    Blood; 2003 May; 101(10):3801-8. PubMed ID: 12515719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis.
    Katoh N; Poshusta TL; Manske MK; Dispenzieri A; Gertz MA; Abraham RS; Ramirez-Alvarado M
    J Clin Immunol; 2011 Dec; 31(6):1029-37. PubMed ID: 21909811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
    Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
    Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
    Abraham RS; Manske MK; Zuckerman NS; Sohni A; Edelman H; Shahaf G; Timm MM; Dispenzieri A; Gertz MA; Mehr R
    J Clin Immunol; 2007 Jan; 27(1):69-87. PubMed ID: 17192818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.
    Prokaeva T; Spencer B; Kaut M; Ozonoff A; Doros G; Connors LH; Skinner M; Seldin DC
    Arthritis Rheum; 2007 Nov; 56(11):3858-68. PubMed ID: 17968927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
    Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
    Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
    Bianchi G; Kumar S
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.
    Perfetti V; Palladini G; Casarini S; Navazza V; Rognoni P; Obici L; Invernizzi R; Perlini S; Klersy C; Merlini G
    Blood; 2012 Jan; 119(1):144-50. PubMed ID: 22067386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models.
    Ohno S; Yoshimoto M; Honda S; Miyachi S; Ishida T; Itoh F; Endo T; Chiba S; Imai K
    J Immunol; 2002 Oct; 169(7):4039-45. PubMed ID: 12244207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
    Gu M; Wilton R; Stevens FJ
    Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
    Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that amyloidogenic light chains undergo antigen-driven selection.
    Perfetti V; Ubbiali P; Vignarelli MC; Diegoli M; Fasani R; Stoppini M; Lisa A; Mangione P; Obici L; Arbustini E; Merlini G
    Blood; 1998 Apr; 91(8):2948-54. PubMed ID: 9531605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
    Abraham RS; Geyer SM; Ramírez-Alvarado M; Price-Troska TL; Gertz MA; Fonseca R
    J Clin Immunol; 2004 Jul; 24(4):340-53. PubMed ID: 15163890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
    Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
    Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.